Fluorescence-guided surgery using cetuximab-800CW in patients with penile carcinoma.

Thomas S NijboerChrista A M van der FelsJaron G de WitBas KeizersHenrik K HuizingaFloris J VoskuilMaarten J H VoskampMarius C van den HeuvelMax J H WitjesIgle Jan de Jong

Published in: BJU international (2024)

In this Phase I study we showed that cetuximab-800CW seems suitable to discriminate PSCC from background tissue. The tracer was well tolerated, and no false positive spots were seen.

Keyphrases

metastatic colorectal cancer
locally advanced
coronary artery bypass
single molecule
prostate cancer
squamous cell carcinoma
positron emission tomography
energy transfer
radical prostatectomy
pet ct